Results 41 to 50 of about 13,156 (215)

Objektivierung von funktionellen und strukturellen Beeinträchtigungen sensorischer Afferenzen bei neuroimmunologischen Krankheitsbildern [PDF]

open access: yes, 2020
In dieser kumulativen Habilitationsschrift werden eigene Arbeiten zusammengefasst, die sich thematisch mit der Objektivierung sensorischer Afferenzstörungen bei neuroimmunologischen Krankheitsbildern befassen. B-mode Ultraschall, eine in der klinischen
Schmidt, Felix Alexander
core   +1 more source

Brainstem involvement - frequency, presentation and outcome [PDF]

open access: yes, 2016
Background Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis (ON) and/or myelitis.
Jarius, Sven   +2 more
core   +1 more source

Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends

open access: yesNeural Regeneration Research
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing.
Xiangjun Li   +6 more
doaj   +1 more source

Neuromyelitis optica spectrum disorder – case report

open access: yesStudia Medyczne, 2016
The study presents the case of a 45-year-old woman with a rare case of Devic’s disease (neuromyelitis optica – NMO) admitted to the Department of Rehabilitation in Kielce.
Grażyna Ściegienna-Zdeb   +1 more
doaj   +1 more source

Aquaporin-4 Antibodies Are Not Related to HTLV-1\ud Associated Myelopathy [PDF]

open access: yes, 2012
Introduction: The seroprevalence of human T-cell leukemia virus type 1 (HTLV-1) is very high among Brazilians (,1:200).\ud HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP) is the most common neurological complication of\ud HTLV-1 ...
Brandão, Carlos Otávio   +12 more
core   +2 more sources

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine

open access: yesCase Reports in Medicine, 2011
Lidocaine unmasks silent symptoms and eases neuropathic pain in multiple sclerosis patients; however, the effects of lidocaine in neuromyelitis optica have never been reported.
Akiyuki Uzawa   +4 more
doaj   +1 more source

Concentrations of B cell-activating factor, aquaporin-4 antibody and brain-derived neurotrophic factor in neuromyelitis optica spectrum disorder

open access: yesTürk Biyokimya Dergisi, 2022
To explore the correlations of B cell-activating factor (BAFF), aquaporin-4 antibody (AQP4-Ab) and brain-derived neurotrophic factor (BDNF) with the severity of neuromyelitis optica spectrum disorder (NMOSD).
Li Suping   +5 more
doaj   +1 more source

The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis [PDF]

open access: yes, 2015
Objective: To describe the clinical activities at the Neuroimmunology Clinic of the Universidade Federal de São Paulo (UNIFESP) from 1994 to 2013. Method: the final diagnosis of all patients that attended the center was reviewed and established upon ...
Bichuetti, Denis Bernardi   +8 more
core   +2 more sources

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing [PDF]

open access: yes, 2018
Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem ...
Aktas, O.   +18 more
core   +9 more sources

Update on neuromyelitis optica spectrum disorder [PDF]

open access: yesCurrent Opinion in Ophthalmology, 2020
Purpose of reviewNeuromyelitis optica spectrum disorder is an autoimmune disease that causes optic neuritis and transverse myelitis. Attacks can cause severe neurological damage leading to blindness and paralysis. Understanding of the immunopathogenesis of this disease has led to major breakthroughs in diagnosis and treatment.
Kathryn B, Holroyd   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy